- Datum18.06.2026
- Uhrzeit17:00 - 17:30 Uhr
- Veranstalter
stock3
Olema Pharmaceuticals Inc. Registered Shares o.N. Chart inkl. Chartanalyse
Charts analysieren
wie die Profis?
Nutze unser Profi-Charting-Tool für Deine eigenen Analysen
Chart analysieren
Realtime-Kurs
| Handelsplatz | Kurs | +/- (%) | +/- (abs) | Vortag | Zeit | Aktionen |
|---|---|---|---|---|---|---|
| Société Générale | VK | |||||
| Nasdaq | VK | |||||
| Nasdaq Basic | VK |
Passende Produkte
| WKN | Long/Short | KO | Hebel | Laufzeit | Bid | Ask |
|---|
Keine Ergebnisse gefunden
Wertentwicklung (Nasdaq)
-10,60 %
Intraday
-10,60 %
1 Woche
-14,75 %
1 Monat
-45,68 %
Seit Jahresbeginn
190,17 %
1 Jahr
94,84 %
3 Jahre
-43,58 %
5 Jahre
Passender Service zu Olema Pharmaceuticals Inc. Registered Shares o.N.
Webinar zu Olema Pharmaceuticals Inc. Registered Shares o.N.
Kursinformationen (Nasdaq)
- Tagestief / Hoch ($)-
- 52W-Tief / Hoch ($)3,890-36,259
- Jahrestief / Hoch ($)---
- Schlusskurs (Vortag)
- Eröffnungskurs
- Volumen Intraday
Wichtigste Eigenschaften
Dividenden von Olema Pharmaceuticals Inc. Registered Shares o.N.
Keine Dividenden verfügbar
Termine von Olema Pharmaceuticals Inc. Registered Shares o.N.
Keine aktuellen Termine
Beschreibung
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, locally advanced, or metastatic estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer. The company was formerly known as CombiThera, Inc. and changed its name to Olema Pharmaceuticals, Inc. in March 2009. Olema Pharmaceuticals, Inc. was incorporated in 2006 and is headquartered in San Francisco, California.
